Mara E. Swan
Known title: DirectorCIK: 0001197529
Associated companies
Transaction History
| BV | ▲ Buy | Grant | 2,625 | $26K | 9/30/2026 | View on chart |
| BV | ▲ Buy | Grant | 1,852 | $26K | 6/30/2026 | View on chart |
| BV | ▲ Buy | Grant | 2,226 | $26K | 3/31/2026 | View on chart |
| BV | ▲ Buy | Option Exercise | 10,894 | — | 3/2/2026 | View on chart |
| BV | ▲ Buy | Grant | 2,071 | $26K | 12/31/2025 | View on chart |
| BV | ▲ Buy | Grant | 1,958 | $26K | 9/30/2025 | View on chart |
| BV | ▲ Buy | Grant | 1,576 | $26K | 6/30/2025 | View on chart |
| BV | ▲ Buy | Grant | 1,849 | $24K | 3/31/2025 | View on chart |
| BV | ▲ Buy | Option Exercise | 13,812 | — | 3/3/2025 | View on chart |
| BV | ▲ Buy | Grant | 1,485 | $24K | 12/31/2024 | View on chart |
| BV | ▲ Buy | Grant | 1,508 | $24K | 9/30/2024 | View on chart |
| BV | ▲ Buy | Grant | 1,785 | $24K | 6/30/2024 | View on chart |
| BV | ▲ Buy | Grant | 1,995 | $24K | 3/31/2024 | View on chart |
| BV | ▲ Buy | Option Exercise | 17,111 | — | 3/4/2024 | View on chart |
| BV | ▲ Buy | Grant | 2,820 | $24K | 12/31/2023 | View on chart |
| BV | ▲ Buy | Grant | 3,064 | $24K | 9/30/2023 | View on chart |
| BV | ▲ Buy | Grant | 3,307 | $24K | 6/30/2023 | View on chart |
| BV | ▲ Buy | Grant | 4,225 | $24K | 3/31/2023 | View on chart |
| BV | ▲ Buy | Option Exercise | 9,086 | — | 3/6/2023 | View on chart |
| BV | ▲ Buy | Grant | 3,447 | $24K | 12/31/2022 | View on chart |
| BV | ▲ Buy | Grant | 2,991 | $24K | 9/30/2022 | View on chart |
| BV | ▲ Buy | Grant | 1,979 | $24K | 6/30/2022 | View on chart |
| BV | ▲ Buy | Grant | 1,745 | $24K | 3/31/2022 | View on chart |
| BV | ▲ Buy | Option Exercise | 7,452 | — | 3/7/2022 | View on chart |
| BV | ▲ Buy | Grant | 1,613 | $23K | 12/31/2021 | View on chart |
| BV | ▲ Buy | Grant | 1,482 | $22K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Morgan Stanley lowers BrightView price target to $11.5
Morgan Stanley kept its equal‑weight rating on BrightView Holdings but cut its price target to $11.5. The new target is below the stock’s recent support level of $12.68. This adjustment reflects a more cautious outlook from the firm. The change can be viewed alongside the company’s current valuation metrics.
Morgan Stanley lowers BrightView price target to $11.5. Morgan Stanley kept its equal‑weight rating on BrightView Holdings but cut its price target to $11.5. The new target is below the stock’s recent support level of $12.68. This adjustment reflects a more cautious outlook from the firm. The change can be viewed alongside the company’s current valuation metrics.